Facial nerve palsy in the setting of malignant hypertension: a link not to be missed.
From the Department of Medicine, Charing Cross Hospital, Department of Neurology, Department of Clinical Pharmacology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK michal.tomek@cantab.net.
M
M
Tomek
From the Department of Medicine, Charing Cross Hospital, Department of Neurology, Department of Clinical Pharmacology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
A
A
Nandoskar
From the Department of Medicine, Charing Cross Hospital, Department of Neurology, Department of Clinical Pharmacology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
N
N
Chapman
From the Department of Medicine, Charing Cross Hospital, Department of Neurology, Department of Clinical Pharmacology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
C
C
Gabriel
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D020330:Bell Palsy / Q000175:diagnosis*; D001539:Bendroflumethiazide / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D005154:Facial Nerve / Q000503:physiopathology*; D005158:Facial Paralysis / Q000503:physiopathology*; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001539:Bendroflumethiazide; D009543:Nifedipine; D017298:Bisoprolol